Concepedia

Gennadiy Poda

GP

21

Publications

1.7K

Citations

17

H-Index

2004

Active since

Affiliations

Pfizer (United States)(Current)

Ontario Institute for Cancer Research

University of Toronto

Structural Genomics Consortium

Helmholtz Zentrum München

Gennadiy Poda is an author at Pfizer (United States) specializing in medicine, drug discovery, and pharmacology.

Top concepts

Publications per year

2004–2015

21

Publications

21

Pharmacological targeting of the Wdr5-MLL interaction in C/EBPα N-terminal leukemia

Florian Grebien, Masoud Vedadi, Matthäus Getlik et al. · Nature Chemical Biology · 2015 · 282 citations · Full text

, , +4

ToxAlerts: A Web Server of Structural Alerts for Toxic Chemicals and Compounds with Potential Adverse Reactions

Iurii Sushko, E.S. Salmina, Vladimir Potemkin et al. · Journal of Chemical Information and Modeling · 2012 · 257 citations · Full text

, , +27

Pyrrolopyridine Inhibitors of Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 (MK-2)

David R. Anderson, Marvin J. Meyers, William F. Vernier et al. · Journal of Medicinal Chemistry · 2007 · 169 citations · Full text

Small-molecule inhibition of MLL activity by disruption of its interaction with WDR5

Guillermo Senisterra, Hong Wu, Abdellah Allali‐Hassani et al. · Biochemical Journal · 2012 · 158 citations · Full text

Structure and mechanism of action of the hydroxy–aryl–aldehyde class of IRE1 endoribonuclease inhibitors

Mário Sanches, Nicole M. Duffy, Manisha Talukdar et al. · Nature Communications · 2014 · 130 citations · Full text

, , +9

Rows per page

1–5 of 21